This inventor holds 2 USPTO granted patents. Top assignees: Nikken Chemicals Co., Ltd., Itto Denko Corporation. Active years: 1997-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Saitama, JP (1997)
- Iwatsuki, JP (1999)
Company Filing History:
2 out of 51 
1 out of 1 Years Active: 1997-1999
Title: Mitsuru Ochiai: Innovator in Transdermal Delivery Systems
Introduction
Mitsuru Ochiai is a prominent inventor based in Saitama, Japan. With a focus on transdermal delivery systems, he has contributed to the field of pharmacology through his innovative inventions. Ochiai holds two patents, showcasing his dedication to advancing medical technologies.
Latest Patents
One of Ochiai's latest patents includes a transdermal administration preparation of a 9-aminocyclopenta compound. This percutaneous absorption preparation excels in enhancing the skin penetration of a non-narcotic analgesic, buprenorphine. The preparation is designed to maintain a high and stable blood level over an extended period. It incorporates a plaster layer containing a pressure-sensitive adhesive and a combination of monoglyceride of fatty acids, specifically those with six to eight carbon atoms, along with isopropyl myristate. The synergistic effect of these penetration enhancers significantly elevates the absorption of buprenorphine hydrochloride and/or buprenorphine.
Career Highlights
Mitsuru Ochiai has made significant strides in his career, notably collaborating with companies like Nikken Chemicals Co., Ltd. and Itto Denko Corporation. His work focuses on innovations that improve healthcare delivery methods, particularly in pain management through effective drug absorption techniques.
Collaborations
Throughout his professional journey, Ochiai has worked alongside esteemed colleagues such as Mutsuo Okumura and Yuko Hosokawa. These collaborations have fostered a dynamic exchange of ideas, further enriching the development of transdermal delivery systems.
Conclusion
In summary, Mitsuru Ochiai stands out as an essential inventor in the realm of drug delivery technologies. His contributions, particularly in transdermal systems for buprenorphine, underline the importance of innovation in improving patient care and managing pain effectively. As he continues to develop new solutions, the impact of his work resonates in the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile